Donidalorsen for hereditary angioedema: Long-term results from a 4-year, phase 2, open-label extension study. - Manning ME; de Lange M; Bernstein JA; Craig T; Lumry WR; Raasch J; Tachdjian R; Bordone L; Deng Y; Newman KB; Cohn DM (Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026)